Document is current
Any future updates will be listed below
-
Authors
Cosgrave, David
McNicholas, Bairbre
Hanley, Ciara
Sheehan, John Robert
Calpin, Padraig
Kernan, Maeve
Murphy, Darragh
Alvarez‑Iglesias, Alberto
Ferguson, John
Giacomini, Camilla
Greene, Christine
Cody, Catriona
McGeary, Shane
Murphy, Marion
Fitzgerald, Marianne
Curley, Gerard
Dixon, Barry
Smith, Roger J.
Masterson, Claire
O’Toole, Daniel
van Haren, Frank
Laffey, John G. https://orcid.org/0000-0002-1246-9573
-
Funding
Funding for this research was provided by:
Science Foundation Ireland (13/RC/2073)
- License Information
-
More Information
Article History
Received: 5 December 2024
Accepted: 29 January 2025
First Online: 7 February 2025
Declarations
:
: Ethics approval was obtained from the National Research Ethics Committee (NREC) in Ireland, approval number 20-NREC-COV-104. Regulatory approval for the study was obtained from the Health Products Regulatory Authority, approval number CT0900/650/001 Heparin Sodium. Written informed consent or assent was obtained from all patients prior to inclusion in the trial for collection, storage, analysis and dissemination of the results of the trial. The trial was conducted in accordance with the Declaration of Helsinki.
: Written informed consent or assent was obtained from all patients prior to inclusion in the trial for publication and dissemination of the results of the trial.Availability of data and materials: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
: JL is a senior editor of Intensive Care Medicine Experimental. JL has received consulting fees from Cellenkos Inc. All other authors declare that they have no competing interests.
